| Literature DB >> 28433227 |
S Ariza1, S Espinosa2, M Naranjo1.
Abstract
Basal cell carcinoma (BCC) is the most prevalent malignant tumor in humans and the local destruction of tissue that can result from excision has a significant impact on well-being. Treating BCC is costly for health care systems given the high incidence of this tumor, especially in older patients. Standard treatment involves either resection with histologic assessment of margins or Mohs micrographic surgery. Surgery is sometimes contraindicated, however, due to the presence of significant comorbidity or high cosmetic expectations. For such patients, nonsurgical treatments have become available. These alternatives can offer good local control of disease, preserve function, and achieve excellent cosmetic results.Entities:
Keywords: Basal cell carcinoma; Carcinoma basocelular; Cáncer de piel; Skin cancer; Tratamiento; Treatment
Mesh:
Substances:
Year: 2017 PMID: 28433227 DOI: 10.1016/j.ad.2017.01.018
Source DB: PubMed Journal: Actas Dermosifiliogr ISSN: 0001-7310